BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38066385)

  • 1. Early assessment of the pharmacokinetic and pharmacodynamic effects following acetylsalicylic acid loading: toward a definition for acute therapeutic response.
    Gurbel PA; Bliden KP; Kundan P; Kraft D; Parekh R; Singh S; Babu AD; Shah AP; Chaudhary R; Tantry US
    J Thromb Thrombolysis; 2024 Jan; 57(1):21-28. PubMed ID: 38066385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining platelet response to acetylsalicylic acid: the relation between inhibition of serum thromboxane B
    Gurbel PA; Bliden KP; Tantry US
    J Thromb Thrombolysis; 2021 Feb; 51(2):260-264. PubMed ID: 33170486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of VerifyNow to assess the immediate pharmacodynamic response of chewed and swallowed aspirin: comparison with aggregometry.
    Bliden KP; Kundan P; Kraft D; Parekh R; Singh S; Babu AD; Shah AP; Tantry US; Gurbel PA
    Platelets; 2024 Dec; 35(1):2298352. PubMed ID: 38166614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment.
    Temperilli F; Rina A; Massimi I; Montemari AL; Guarino ML; Zicari A; Pulcinelli FM
    Platelets; 2015; 26(8):783-7. PubMed ID: 25734355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover study.
    Franchi F; Schneider DJ; Prats J; Fan W; Rollini F; Been L; Taatjes-Sommer HS; Bhatt DL; Deliargyris EN; Angiolillo DJ
    J Thromb Thrombolysis; 2022 Oct; 54(3):373-381. PubMed ID: 36036856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of plasma concentrations of salicylic acid and high on ASA platelet reactivity in type 2 diabetes patients.
    Postula M; Janicki PK; Rosiak M; Przybylkowski A; Kaplon-Cieslicka A; Grygorowicz T; Trzepla E; Filipiak KJ; Czlonkowski A; Opolski G
    Cardiol J; 2013; 20(2):170-7. PubMed ID: 23558875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial to assess the pharmacodynamics and pharmacokinetics of a single dose of an extended-release aspirin formulation.
    Patrick J; Dillaha L; Armas D; Sessa WC
    Postgrad Med; 2015 Aug; 127(6):573-80. PubMed ID: 25998572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
    Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
    Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective, randomised trial of the time dependent antiplatelet effects of 500 mg and 250 mg acetylsalicylic acid i. v. and 300 mg p. o. in ACS (ACUTE).
    Zeymer U; Hohlfeld T; Vom Dahl J; Erbel R; Münzel T; Zahn R; Roitenberg A; Breitenstein S; Pap ÁF; Trenk D
    Thromb Haemost; 2017 Feb; 117(3):625-635. PubMed ID: 28102427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of very low dose and enteric-coated acetylsalicylic acid on prostacyclin and thromboxane formation and on bleeding time in healthy subjects.
    Bode-Böger SM; Böger RH; Schubert M; Frölich JC
    Eur J Clin Pharmacol; 1998; 54(9-10):707-14. PubMed ID: 9923572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable platelet response to aspirin in patients with ischemic stroke.
    Hohlfeld T; Weber AA; Junghans U; Schumacher M; Boucher M; Schrör K; Siebler M
    Cerebrovasc Dis; 2007; 24(1):43-50. PubMed ID: 17519543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production.
    Cattaneo M; Tenconi PM; Lecchi A; Mannucci PM
    Thromb Res; 1991 Jun; 62(6):717-24. PubMed ID: 1926062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylsalicylic acid in critically ill patients: a cross-sectional and a randomized trial.
    Schoergenhofer C; Hobl EL; Schwameis M; Gelbenegger G; Staudinger T; Heinz G; Speidl WS; Zauner C; Reiter B; Lang I; Jilma B
    Eur J Clin Invest; 2017 Jul; 47(7):504-512. PubMed ID: 28556061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet aggregation and thromboxane release induced by arachidonic acid, collagen, ADP and platelet-activating factor following low dose acetylsalicylic acid in man.
    Küster LJ; Frölich JC
    Prostaglandins; 1986 Sep; 32(3):415-23. PubMed ID: 3097760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of high platelet reactivity during aspirin treatment in patients with type 2 diabetes.
    Kapłon-Cieślicka A; Rosiak M; Postuła M; Serafin A; Kondracka A; Opolski G; Filipiak KJ
    Kardiol Pol; 2013; 71(9):893-902. PubMed ID: 24065375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the pharmacodynamics of acetylsalicylic acid 81 mg with or without esomeprazole 20 mg in healthy volunteers.
    Andersson T; Morrison D; Nagy P; Pisupati J; Schettler J; Warner TD
    Am J Cardiovasc Drugs; 2012 Aug; 12(4):217-24. PubMed ID: 22631032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with Essential Thrombocythemia may be Poor Responders to Enteric-Coated Aspirin, but not to Plain Aspirin.
    Scavone M; Rizzo J; Femia EA; Podda GM; Bossi E; Caberlon S; Paroni R; Cattaneo M
    Thromb Haemost; 2020 Oct; 120(10):1442-1453. PubMed ID: 32717754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of acetylsalicylic acid on plasma thromboxane B2 and platelet aggregation in man.
    Nuotto E; Gordin A; Paasonen MK; Metsä-Ketelä T; Lamminsivu U
    Eur J Clin Pharmacol; 1983; 25(3):313-7. PubMed ID: 6628518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamics and pharmacokinetics of a novel, low-dose, soft-gel capsule of acetylsalicylic acid in comparison with an oral solution after single-dose administration to healthy volunteers: a phase I, two-way crossover study.
    Loprete L; Leuratti C; Scarsi C; Radicioni M
    Clin Drug Investig; 2014 Jan; 34(1):19-25. PubMed ID: 24132773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of methods to evaluate aspirin-mediated platelet inhibition after percutaneous intervention with stent implantation.
    Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
    Platelets; 2011; 22(3):188-95. PubMed ID: 21231857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.